Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

US stops Johnson and Johnson COVID-19 vaccine use over rare blood clots

Ruchika Sharma14 April 2021 1:12 PM IST

New Delhi: U.S. federal health agencies on Tuesday recommended pausing use of Johnson & Johnson's Covid-19 vaccine for at least a few days after...

Pfizer to pursue bringing COVID-19 vaccine developed with BioNTech to India after import relaxation

Ruchika Sharma14 April 2021 12:33 PM IST

New Delhi: Pfizer Inc said on Tuesday it would work towards bringing the COVID-19 vaccine it developed with Germany's BioNTech to India after the...

Gennova begins enrolment for Phase human clinical trials of HGCO19 vaccine candidate

Ruchika Sharma13 April 2021 5:38 PM IST

New Delhi: Gennova has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, the Department of...

Cipla doubles covid drug remdesivir production to meet unprecedented demand

Ruchika Sharma13 April 2021 4:34 PM IST

The company is working with authorities to restrict remdesivir supply just to hospitals and places with a high burden of severe COVID-19 cases, Cipla...

COVID-19: Centre fast-tracks approval for foreign-produced vaccines cleared in other countries

Ruchika Sharma13 April 2021 2:29 PM IST

New Delhi: With an aim to expand the basket of COVID-19 vaccines and enhance the pace of inoculation in India, the central government on Tuesday...

DCGI authorizes Sputnik V for emergency use in India

Ruchika Sharma13 April 2021 11:30 AM IST

New Delhi: India''s drug regulator has granted permission for the restricted emergency use of Russian COVID-19 vaccine '"Sputnik V" with certain...

Vivek Kanade elevated as Siemens Healthcare India MD

Ruchika Sharma13 April 2021 10:00 AM IST

Mumbai: Siemens Healthcare India has elevated Vivek Kanade as Managing Director Operations effective April 1.Kanade, who joined the company 27 years...

AstraZeneca discontinues Phase 3 trial of prostate cancer drug Truqap

Diabetes drug Farxiga fails in trial to treat covid patients: AstraZeneca

Ruchika Sharma12 April 2021 6:10 PM IST

UK: Data from a late-stage study to test if AstraZeneca's diabetes drug Farxiga could treat patients hospitalised with COVID-19 and at risk of...

Biocon sells 80 lacs equity shares of Syngene International

Biocon arm gets GMP compliance certificate from MHRA, UK

Ruchika Sharma12 April 2021 4:21 PM IST

Bangalore: Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, today announced that the company has received a certificate of Good ...

Natco Pharma gets USFDA nod for Ibrutinib tablets in US

Ruchika Sharma12 April 2021 1:52 PM IST

Hyderabad: Drugmaker, NATCO Pharma Limited, has recently announced that the company's marketing and distribution partner Alvogen Pine Brook LLC, has...

Nitin Gadkari dials Sun Pharma chief to cope with Remdesivir shortage in Nagpur

Ruchika Sharma12 April 2021 1:37 PM IST

Nagpur: Union minister Nitin Gadkari has called up Sun Pharma's chief to arrange for 10,000 injections of Remdesivir in Nagpur in view of a shortage...

India to have 5 more COVID vaccines by Oct

Ruchika Sharma12 April 2021 12:02 PM IST

These vaccines are Sputnik V vaccine, Johnson and Johnson vaccine, Novavax vaccine, Zydus Cadila's vaccine, and Bharat Biotech's Intranasal Vaccine.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok